Considerations for Implementing Decentralized Clinical Trials

The COVID-19 pandemic has accelerated the implementation of decentralized solutions—also referred to as virtual, remote, or hybrid—for clinical trials. Using our collaborative, cross-functional base of knowledge, our experts have compiled key considerations for designing and executing successful decentralized solutions.

Download this article to learn more about:

  • Formal risk analysis as the foundation for decentralized solutions
  • Remote processes for consent, recruitment, and enrollment
  • Telemedicine visits and Home Health Care
  • Direct to Patient (DTP) shipments of Investigational Product (IP)
  • Technology solutions
  • Remote and centralized monitoring